• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific swings to black for Q4, 2016

Boston Scientific swings to black for Q4, 2016

February 2, 2017 By Brad Perriello

Boston ScientificBoston Scientific (NYSE:BSX) put black ink in the ledger for the 4th quarter and 2016 today, beating the sales and earnings consensus for both periods in the process.

The Marlborough, Mass.-based medical device company posted profits of $124 million, or 9¢ per share, on sales of $2.19 billion for the 3 months ended Dec. 31, for a 10.8% top-line gain compared with Q4 2015, when Boston Scientific put up a loss of -$142 million.

Adjusted to exclude 1-time items, earnings per share were 30¢, a penny ahead of the consensus on Wall Street, where analysts were looking for sales of $2.16 billion.

Full-year profits were $347 million, or 25¢ per share, on sales of $8.39 billion, amounting to a 12.2% sales increase over 2015, when losses were -$239 million. Adjusted EPS for 2016 came in at $1.11, again ahead of The Street by 1¢; analysts were looking for annual sales of $8.35 billion.

“Boston Scientific delivered excellent financial results in 2016, with accelerated revenue growth, improved profitability, and strong double-digit adjusted EPS growth,” chairman & CEO Mike Mahoney said in prepared remarks. “Our strategy of category leadership in key markets and diversification into high-growth adjacencies is working, and enabling continued investment in innovative medical technologies. I want to thank our employees for their commitment to advancing science and improving the lives of patients around the world.”

Boston Scientific said it expects to report adjusted EPS of $1.22 to $1.26 on sales of $8.68 billion to $8.88 billion this year. First-quarter adjusted EPS are pegged at 29¢ to 31¢ on sales of $2.05 billion to $2.10 billion, the company said.

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Boston Scientific

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy